A 42-year-old woman on olanzapine 15 mg/day for bipolar disorder type I presents with progressive muscle rigidity, fever (39.2°C), altered mental status, and serum creatinine 2.1 mg/dL (baseline 0.9). Her CPK is 1850 U/L. What is the most appropriate investigation to confirm the suspected diagnosis?

Explanation

## Confirming Neuroleptic Malignant Syndrome (NMS): Role of Urine Myoglobin ### Clinical Presentation Recognition The classic **NMS tetrad** is present: 1. **Antipsychotic exposure** (olanzapine 15 mg/day) 2. **Hyperthermia** (39.2°C) 3. **Muscle rigidity** (progressive) 4. **Altered mental status** Additionally, **elevated CPK (1850 U/L)** and **acute kidney injury** (creatinine 2.1 vs. baseline 0.9 mg/dL) indicate secondary **rhabdomyolysis with myoglobinuric AKI** — a life-threatening complication of NMS. ### Why Urine Myoglobin (Option C) is the Most Appropriate Confirmatory Investigation **Key Point:** In the context of suspected rhabdomyolysis-induced AKI (as seen here), **urine myoglobin** — assessed by dipstick (positive for blood without RBCs) and microscopy (myoglobin casts) — is the **most specific and clinically actionable confirmatory test** for myoglobinuria causing renal tubular injury. Myoglobin (17 kDa) is freely filtered at the glomerulus. In acidic urine, it precipitates and causes **acute tubular necrosis**. Detecting myoglobin in urine directly confirms the mechanism of AKI and guides management (aggressive IV hydration, urinary alkalinization). ### Why NOT Serum Myoglobin (Option A)? **Clinical Pearl:** Serum myoglobin is **sensitive but not specific or reliable** as a confirmatory test: - It has a **very short half-life (~1–3 hours)** and is rapidly cleared by the kidneys; levels may already be falling or normalized by the time the patient presents. - It is **less stable** than urine myoglobin for diagnostic purposes. - Serum myoglobin elevation is **nonspecific** (seen in any muscle injury, MI, etc.) and does not directly confirm the renal mechanism. - In contrast, **urine myoglobin persists longer** and directly implicates the kidney, making it the preferred confirmatory test when AKI is present. *(Harrison's Principles of Internal Medicine, 21e, Ch. 385: "Urine myoglobin is the most specific test for myoglobinuric renal failure; serum myoglobin is less reliable due to rapid clearance.")* ### Diagnostic Hierarchy for NMS-Associated Rhabdomyolysis | Test | Sensitivity | Specificity | Clinical Use | |---|---|---|---| | **Urine myoglobin** | High | **Highest** | **Confirms rhabdomyolysis + AKI mechanism** | | Serum myoglobin | High | Moderate | Rises & falls rapidly; less reliable | | CPK | Very high | Low | Nonspecific; elevated in many conditions | | Urine dipstick (blood +, RBC −) | High | High | Screening; suggests myoglobinuria | | EMG | Low | Low | Not diagnostic for NMS | | Muscle biopsy | N/A | N/A | Invasive; no role in acute NMS | ### Why Other Options Are Incorrect - **Option A (Serum myoglobin):** Sensitive but rapidly cleared; less reliable than urine myoglobin when AKI is already established. - **Option B (Muscle biopsy):** Invasive, time-consuming, and has no role in acute NMS management. - **Option D (EMG):** Useful for neuromuscular disorders (e.g., myopathies, neuropathies) but not diagnostic for NMS or rhabdomyolysis. **High-Yield Mnemonic — CHAMP** (Confirmatory tests in NMS rhabdomyolysis): - **C**PK (elevated, nonspecific) - **H**yperkalemia / **H**yperphosphatemia (electrolyte derangements) - **A**cute kidney injury (myoglobinuric) - **M**yoglobin in **urine** ← *most specific confirmatory test* - **P**ositive urine dipstick (blood without RBCs on microscopy) [cite: Harrison's Principles of Internal Medicine 21e Ch 385; Kaplan & Sadock's Synopsis of Psychiatry 12e Ch 29; Tintinalli's Emergency Medicine 9e Ch 185]